Wednesday, December 6, 2017

Dr. Furman on The Diminishing Role of FCR in CLL (chronic lymphocytic leukemia)

As we're getting ready to head to ASH this week, we wanted to post in response to a query that was posted originally on the CLLSLL io group forum. Dr. Richard Furman is their medical advisor and his response really puts the comparison of a therapy that has existed for decades with a therapy that is less than a decade old. You can read my commentary and the text from Dr. Furman's post https://cllsociety.org/2017/12/one-mans-opinion-fcr-vs-ibrutinib/.

We'll be going night and day at ASH and plan to post while we are there. Stay tuned.

0 Comments:

Post a Comment

Subscribe to Post Comments [Atom]

<< Home